FEATURED TOP LISTS Follow us on twitter
AppAdvice AppAdvice/TV WatchAware

CareMate® mBC is a treatment management app that has been designed to help people get the most out of their treatment while on therapy

CareMate mBC NZ

by Pfizer Inc

What is it about?

CareMate® mBC is a treatment management app that has been designed to help people get the most out of their treatment while on therapy. CareMate® mBC can help remind people when to take their medication, be a health diary, help manage potential symptoms and allow the user to share all of these important updates in one easy report with their doctor.

App Details

Version
1.4.2
Rating
NA
Size
12Mb
Genre
Medical
Last updated
April 18, 2024
Release date
April 24, 2018
More info

App Screenshots

App Store Description

CareMate® mBC is a treatment management app that has been designed to help people get the most out of their treatment while on therapy. CareMate® mBC can help remind people when to take their medication, be a health diary, help manage potential symptoms and allow the user to share all of these important updates in one easy report with their doctor.

The symptom tips found within the app are guides only to help manage symptoms – they do not replace the advice of a healthcare professional.

IBRANCE® Prescription Medicine. For the treatment of HR+, HER2- advanced breast cancer taken in combination with an aromatase inhibitor or fulvestrant.
IBRANCE® has risks and benefits. IBRANCE® (palbociclib 75 mg, 100 mg and 125 mg) Capsules and Tablets.
For Consumer Medicine Information refer to www.medsafe.govt.nz
IBRANCE® and CareMate® are registered trademarks. Pfizer New Zealand Limited. Auckland.
PP-IBR-NZL-0191-May 2022. TAPS NP18109

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.